1. lncRNA TMPO antisense RNA 1 promotes the malignancy of cholangiocarcinoma cells by regulating let-7g-5p/ high-mobility group A1 axis.
- Author
-
Chang H and Yao Y
- Subjects
- Adult, Aged, Aged, 80 and over, Animals, Bile Duct Neoplasms genetics, Bile Ducts, Intrahepatic metabolism, Bile Ducts, Intrahepatic pathology, Cell Line, Tumor, Cell Proliferation genetics, Cell Transformation, Neoplastic genetics, Cholangiocarcinoma genetics, Female, Gene Expression Regulation, Neoplastic, Humans, Male, Mice, Mice, Inbred BALB C, Mice, Nude, Middle Aged, Nuclear Proteins antagonists & inhibitors, RNA, Antisense physiology, RNA, Long Noncoding physiology, Thymopoietins antagonists & inhibitors, Bile Duct Neoplasms pathology, Cholangiocarcinoma pathology, HMGA1a Protein genetics, MicroRNAs genetics, Nuclear Proteins genetics, Thymopoietins genetics
- Abstract
Cholangiocarcinoma (CHOL) is often diagnosed at an advanced stage; therefore, exploring its key regulatory factors is important for earlier diagnosis and treatment. This study aimed to identify the mechanisms of long non-coding RNA (lncRNA) TMPO Antisense RNA 1 (TMPO-AS1), microRNA let-7 g-5p, and high-mobility group A1 (HMGA1) proteins in CHOL. Our results, through quantitative real-time PCR and Western blot detection, showed that TMPO-AS1 and HMGA1 were overexpressed while let-7 g-5p was underexpressed in CHOL. Cell function experiments in CHOL cells revealed that TMPO-AS1 knockdown inhibited cell proliferation, colony formation, and cell migration, but induced apoptosis. TMPO-AS1 knockdown also suppressed tumor growth in vivo. Together with luciferase assay and Western blotting, we found that TMPO-AS1 could sponge let-7 g-5p to promote HMGA1 expression. Moreover, HMGA1 overexpression attenuated the effect of TMPO-AS1 downregulation in CHOL cells. Overall, our findings identified the oncogenic effect of TMPO-AS1 on CHOL cells, which may put forward a novel methodology for CHOL diagnosis and therapy.
- Published
- 2022
- Full Text
- View/download PDF